Evidence map›Paper›PMID 28332827›Full record

ArticleAnalytical chemistry2017

Subcellular Chemical Imaging of Antibiotics in Single Bacteria Using C

Hua Tian, David A Six, Thomas Krucker, Jennifer A Leeds, Nicholas Winograd

Abstract read
In one paragraph

Article in Analytical chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Mass Spectrometry Imaging.Analytical chemistry · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Advances in Mass Spectrometry-Metabolomics Based Approaches.Advances in experimental medicine and biology · 2023
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Permeability barriers of Gram-negative pathogens.Annals of the New York Academy of Sciences · 2020
    Review
  18. A How-To Guide for Mode of Action Analysis of Antimicrobial Peptides.Frontiers in cellular and infection microbiology · 2020
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Hua TianDepartment of Chemistry, Pennsylvania State University , University Park, Pennsylvania 16802, United States.ORCID 0000-0002-3598-0219
David A SixNovartis Institutes for BioMedical Research, Inc., 5300 Chiron Way, Emeryville, California 94608-2916, United States.
Thomas KruckerNovartis Institutes for BioMedical Research, Inc., 5300 Chiron Way, Emeryville, California 94608-2916, United States.
Jennifer A LeedsNovartis Institutes for BioMedical Research, Inc., 5300 Chiron Way, Emeryville, California 94608-2916, United States.ORCID 0000-0003-2244-4713
Nicholas WinogradDepartment of Chemistry, Pennsylvania State University , University Park, Pennsylvania 16802, United States.
Novartis (United States) · USPennsylvania State University · US

Funding

Molecular Imaging of Biomaterials - Single CellsR01GM113746 · NIGMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI WINOGRAD, NICHOLAS · 2014 to 2017
$1.7M
NIGMS NIH HHS R01 GM113746
6 · The paper itself

Abstract

The inherent difficulty of discovering new and effective antibacterials and the rapid development of resistance particularly in Gram-negative bacteria, illustrates the urgent need for new methods that enable rational drug design. Here we report the development of 3D imaging cluster Time-of-Flight secondary ion mass spectrometry (ToF-SIMS) as a label-free approach to chemically map small molecules in aggregated and single Escherichia coli cells, with ∼300 nm spatial resolution and high chemical sensitivity. The feasibility of quantitative analysis was explored, and a nonlinear relationship between treatment dose and signal for tetracycline and ampicillin, two clinically used antibacterials, was observed. The methodology was further validated by the observation of reduction in tetracycline accumulation in an E. coli strain expressing the tetracycline-specific efflux pump (TetA) compared to the isogenic control. This study serves as a proof-of-concept for a new strategy for chemical imaging at the nanoscale and has the potential to aid discovery of new antibacterials.

Indexed as

AmpicillinAnti-Bacterial AgentsDose-Response Relationship, DrugEscherichia coliLimit of DetectionSingle-Cell AnalysisSpectrometry, Mass, Secondary IonTetracyclineAmpicillinAnti-Bacterial AgentsTetracycline

Identifiers

PMID28332827
PMCPMC5415874
OpenAlexW2600724618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.